HealthEquity (NASDAQ:HQY) Given Outperform Rating at Barrington Research

Barrington Research reissued their outperform rating on shares of HealthEquity (NASDAQ:HQY) in a research report sent to investors on Friday morning,Benzinga reports. Barrington Research currently has a $112.00 price objective on the stock.

Several other analysts have also recently commented on the company. The Goldman Sachs Group dropped their price target on HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research report on Thursday, March 27th. Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and dropped their target price for the stock from $120.00 to $115.00 in a report on Tuesday, March 25th. Wells Fargo & Company raised their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. Finally, KeyCorp dropped their price objective on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Monday, March 24th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, HealthEquity has an average rating of “Buy” and a consensus price target of $112.58.

HealthEquity Trading Up 2.8 %

Shares of HealthEquity stock opened at $82.20 on Friday. HealthEquity has a twelve month low of $65.01 and a twelve month high of $115.59. The firm’s 50-day moving average price is $97.63 and its 200 day moving average price is $96.42. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $7.11 billion, a PE ratio of 75.41, a P/E/G ratio of 1.60 and a beta of 0.49.

Insider Buying and Selling

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the business’s stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company’s stock, valued at $4,433,820.30. The trade was a 13.55 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 20,381 shares of company stock worth $1,781,432. Company insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Several institutional investors and hedge funds have recently modified their holdings of the company. Wealthfront Advisers LLC purchased a new position in HealthEquity in the 4th quarter valued at approximately $10,304,089,000. Vanguard Group Inc. boosted its holdings in HealthEquity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock valued at $861,256,000 after purchasing an additional 99,624 shares during the period. FMR LLC grew its stake in HealthEquity by 2.4% during the 4th quarter. FMR LLC now owns 5,415,800 shares of the company’s stock worth $519,646,000 after purchasing an additional 125,684 shares in the last quarter. Geode Capital Management LLC increased its holdings in HealthEquity by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company’s stock worth $200,522,000 after purchasing an additional 10,421 shares during the period. Finally, Brown Advisory Inc. increased its holdings in HealthEquity by 12.0% during the 4th quarter. Brown Advisory Inc. now owns 2,086,026 shares of the company’s stock worth $200,154,000 after purchasing an additional 224,016 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.